The inhibition of Erk and p38 was then found to be involved in MMP-2 and MMP-9 expression, which revealed naringenin’s ability to inhibit the migration of glioblastoma cells [88,89,90,91]. The gene discussed is MMP9; the disease is glioblastoma.